Drug Discovery Informatics Market Scope And Analysis

Report Code : TIPHE100000965
Category : Life Sciences

No. of Pages : 150

Buy Now

Drug Discovery Informatics Market Analysis and Scope (2021 to 2022)

Buy Now

Drug Discovery Informatics Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 3.07 Billion
Market Size by 2031	US$ 8.17 Billion
Global CAGR (2023 - 2031)	13.0%
Historical Data	2021-2023
Forecast period	2023-2031
Segments Covered	By Workflow Discovery Informatics and Drug Development By Service Sequence Analysis Platform Molecular Modeling Clinical Trial Data Management Docking By Solution Software and Services By End User Pharmaceutical and Biotechnology Companies Contract Research Organizations
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Certara Infosys Ltd Collaborative Drug Discovery Inc Jubliant Biosys Curia Global Inc Chemaxon Ltd Charles River Laboratories Agilent Technologies Inc Illumina Inc

Industry Developments and Future Opportunities:

As per company press releases, a few initiatives taken by key players operating in the global drug discovery informatics market are listed below:

In January 2024, Evotec partnered with the Crohn's & Colitis Foundation to develop new treatments for inflammatory bowel disease (IBD). Under this partnership, both companies will use Evotec's comprehensive R&D platform to advance drug discovery for two innovative drug targets that address fibrosis and impaired intestinal barrier function.
In November 2023, Certara introduced Simcyp Biopharmaceutics software, which aims to increase the efficiency of formulation development for new and generic drugs. The Simcyp Biopharmaceutics software is designed to assist biopharmaceutics, formulation, and scientists in quickly and cost-effectively formulating complex, novel, and generic small molecule medicines.
In June 2022, Chemical.AI and Chemaxon announced a collaboration to integrate their scientific informatics software. Chemical.AI, a renowned Artificial Intelligence (AI) firm, announced a strategic partnership with Chemaxon, a leading chemical and biological software development company. The collaboration allows end users to access Chemaxon's Design Hub and Chemical.AI's ChemAIRS as an option.
In April 2022, Certara, Inc. and Chemaxon entered a strategic partnership to modernize pharmaceutical research. The partnership provides interconnectivity between their scientific informatics workflows. Certara's Scientific Informatics software will seamlessly connect with Chemaxon's Design Hub, providing users with analytics and compound design. This co-development builds on integrations between Certara and Chemaxon products, such as the JChem chemistry cartridge, MarvinSketch, and JChem for Office.

Competitive Landscape and Key Companies:

Certara; Infosys Ltd.; Collaborative Drug Discovery, Inc.; Jubliant Biosys; Curia Global, Inc.; Chemaxon Ltd; Charles River Laboratories; Agilent Technologies, Inc.; Illumina, Inc; Boehringer Ingelheim International GmbH; and Evotec are among the prominent companies profiled in drug discovery informatics market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.